Abstract
Human histocompatibility leukocyte antigen (HLA)-DM is a major histocompatibility complex (MHC)-like protein that catalyzes exchange of antigenic peptides from MHC class II molecules. To investigate the molecular details of this catalysis we created four covalent complexes between HLA-DM and the MHC class II allele DR1. We introduced a disulfide bond between the naturally occurring cysteine beta46 on HLA-DM and an engineered cysteine on the end of a linker attached to either the NH(2)- or the COOH terminus of an antigenic peptide that is tightly bound on DR1. We find that when DM is attached to the NH(2) terminus of the peptide, it can, for all linker lengths tested, catalyze exchange of the peptide with a half-life a few minutes (compared with uncatalyzed t(1/2) > 100 h). This rate, which is several orders of magnitude greater than the one we obtain in solution assays using micromolar concentrations of HLA-DM, is dominated by a concentration independent factor, indicating an intramolecular catalytic interaction within the complex. A similar complex formed at the COOH terminus of the peptide shows no sign of DM-specific intramolecular catalysis. Restrictions on the possible interaction sites imposed by the length of the linkers indicate that the face of DR1 that accommodates the NH(2) terminus of the antigenic peptide interacts with the lateral face of HLA-DM that contains cysteine beta46.
MeSH Terms
Amino Acid Sequence
Animals
Binding Sites
Catalysis
Cell Line
Cysteine/chemistry
HLA-D Antigens/chemistry,genetics,metabolism
HLA-DR1 Antigen/chemistry,genetics,metabolism
Humans
In Vitro Techniques
Kinetics
Macromolecular Substances
Models, Molecular
Molecular Sequence Data
Oligopeptides/chemistry,genetics,metabolism
Protein Conformation
Recombinant Proteins/chemistry,genetics,metabolism
Chemicals
HLA-D Antigens
HLA-DM antigens
HLA-DR1 Antigen
Macromolecular Substances
Oligopeptides
Recombinant Proteins
Cysteine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Stratikos Efstratios
Department of Cellular and Molecular Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA.
[email protected]
Mosyak Lidia
Zaller Dennis M
Wiley Don C
References (27)
27 references, click to expand
-
Deviant trafficking of I-Ad mutant molecules is reflected in their peptide binding properties.
Eur J Immunol. 1999 Sep;29(9):2729-39
PMID: 10508247
-
Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes.
J Immunol. 1999 Oct 1;163(7):3567-71
PMID: 10490947
-
Determinants of the peptide-induced conformational change in the human class II major histocompatibility complex protein HLA-DR1.
J Biol Chem. 2000 Jan 21;275(3):2165-73
PMID: 10636922
-
HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.
J Exp Med. 2000 Dec 18;192(12):1697-706
PMID: 11120767
-
Determination of the HLA-DM interaction site on HLA-DR molecules.
Immunity. 2000 Oct;13(4):517-27
PMID: 11070170
-
Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9231-6
PMID: 11470892
-
Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity.
J Immunol. 2001 Nov 1;167(9):5167-74
PMID: 11673529
-
The kinetic basis of peptide exchange catalysis by HLA-DM.
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12450-5
PMID: 11606721
-
A precise method for the determination of whole blood and plasma sulfhydryl groups.
Anal Biochem. 1979 Feb;93(1):98-102
PMID: 434474
-
Interaction between proteins localized in membranes.
Proc Natl Acad Sci U S A. 1986 Sep;83(17):6258-62
PMID: 3018721
-
A kinetic intermediate in the reaction of an antigenic peptide and I-Ek.
Nature. 1989 Jan 19;337(6204):274-6
PMID: 2536141
-
Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.
Nature. 1990 Jun 14;345(6276):615-8
PMID: 2190094
-
Structural and functional aspects of HLA class II glycoproteins and the associated invariant chain.
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:309-18
PMID: 2639757
-
Structural intermediates in the reactions of antigenic peptides with MHC molecules.
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:409-16
PMID: 2639762
-
A new human HLA class II-related locus, DM.
Nature. 1991 Oct 10;353(6344):571-3
PMID: 1922365
-
The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.
Cell. 1992 Feb 7;68(3):465-77
PMID: 1371238
-
An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
Nature. 1994 Apr 7;368(6471):551-4
PMID: 8139689
-
Mediation by HLA-DM of dissociation of peptides from HLA-DR.
Nature. 1995 Jun 29;375(6534):802-6
PMID: 7596415
-
HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.
Cell. 1995 Jul 14;82(1):155-65
PMID: 7606781
-
DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.
Immunity. 1995 Aug;3(2):197-205
PMID: 7648393
-
HLA-DM: an in vivo facilitator of MHC class II peptide loading.
Immunity. 1995 Sep;3(3):259-62
PMID: 7552991
-
The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
Nature. 1995 Nov 30;378(6556):457-62
PMID: 7477400
-
Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.
Science. 1996 Oct 25;274(5287):618-20
PMID: 8849454
-
Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localization.
J Immunol. 1998 May 1;160(9):4289-97
PMID: 9574531
-
The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
Immunity. 1998 Sep;9(3):377-83
PMID: 9768757
-
Crystal structure of mouse H2-M.
Immunity. 1998 Sep;9(3):385-93
PMID: 9768758
-
X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.
Immunity. 1997 Oct;7(4):473-81
PMID: 9354468